Sofinnova Venture Partners X, L.P. - 10 Dec 2025 SCHEDULE 13D/A Report for Vera Therapeutics, Inc. Class A Common Stock, $0.001 par value (VERA)

Filing Manager
Sofinnova Venture Partners X, L.P.
Reporting Manager
Dr. Maha Katabi ("Katabi")
Security
Vera Therapeutics, Inc. Class A Common Stock, $0.001 par value
Symbol
VERA
Shares outstanding
71,195,925 shares
Disclosed Ownership
2,847,837 shares
Ownership
4%
Form type
SCHEDULE 13D/A
Filing time
05 Mar 2026, 06:11:20 UTC
Date of event
10 Dec 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sofinnova Venture Partners X, L.P. ("SVP X") 3.9% 2,793,987 2,793,987 0 /s/ Nathalie Auber Nathalie Auber / Attorney-in-Fact 0001680200
Sofinnova Management X, L.P. ("SM X LP") 3.9% 2,793,987 2,793,987 0 /s/ Nathalie Auber Nathalie Auber / Attorney-in-Fact
Sofinnova Management X-A, L.L.C. ("SM X LLC") 3.9% 2,793,987 2,793,987 0 /s/ Nathalie Auber Nathalie Auber / Attorney-in-Fact
Dr. James I. Healy ("Healy") 3.9% 2,793,987 0 2,793,987 /s/ Nathalie Auber Nathalie Auber / Attorney-in-Fact
Dr. Maha Katabi ("Katabi") 4% 2,847,837 53,850 2,793,987 /s/ Nathalie Auber Nathalie Auber / Attorney-in-Fact